Núria
Camarero†
a,
Ana
Trapero†
ab,
Ariadna
Pérez-Jiménez
a,
Eric
Macia
c,
Alexandre
Gomila-Juaneda
a,
Andrés
Martín-Quirós
a,
Laura
Nevola‡
d,
Artur
Llobet
ef,
Amadeu
Llebaria
b,
Jordi
Hernando
g,
Ernest
Giralt
dh and
Pau
Gorostiza
*aij
aInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Spain. E-mail: pau@icrea.cat
bInstitute for Advanced Chemistry of Catalonia (IQAC-CSIC), Spain
cInstitut de Pharmacologie Moléculaire et Cellulaire (IPMC), Université Nice Sophia Antipolis, France
dInstitute for Research in Biomedicine (IRB Barcelona), Spain
eBellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
fDepartment of Pathology and Experimental Therapy, Faculty of Medicine and Health Science, Institute of Neurosciences, University of Barcelona, 08907 L’Hospitalet de Llobregat, Barcelona, Spain
gDepartament de Química, Universitat Autònoma de Barcelona (UAB), Spain
hUniversitat de Barcelona (UB), Spain
iCIBER-BBN, Spain
jICREA, Spain
First published on 1st September 2020
Correction for ‘Photoswitchable dynasore analogs to control endocytosis with light’ by Núria Camarero et al., Chem. Sci., 2020, 11, 8981–8988, DOI: 10.1039/d0sc03820b.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnotes |
† NC and AT contributed equally. |
‡ Present address: IDP Discovery Pharma, Parc Científic de Barcelona (PCB), Spain. |
This journal is © The Royal Society of Chemistry 2020 |